Phase I 2-Way Crossover Study to Assess Relative BA of Tablet Versus Liquid Suspension and Food Effect on Tablet Formulation

Completed · Phase 1

Conditions studied: Healthy

In brief

The purpose of this study is to compare the liquid suspension form of AZD 2624 to a tablet form of the same drug. This study will also study the effect of food on the tablet form of the drug.

Key facts

Study ID

NCT00867685

Run by

AstraZeneca

People needed

16

Starts

2009-03-01

Expected to finish

2009-04-01

Last updated by the study team

2009-04-30

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male and female volunteers

You may not qualify if…

• Donation of plasma or blood products within one month of of screening
• Clinically relevant abnormalities in physical examination, vital signs,ECG, clinical chemistry, hematology, or urinalysis.
• Previous participation in an AD2624 study.

Where it is running

• Research Site — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.